Published date: 10 March 2017
This notice was replaced on 31 March 2017
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Future opportunity (published 31 March 2017)
Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.
Contract summary
Industry
Blood coagulants - 33141530
Location of contract
Any region
Value of contract
£4,140,000
Procurement reference
CM/PHS/17/5535
Published date
10 March 2017
Approach to market date
9 May 2017
Contract start date
1 October 2017
Contract end date
30 September 2018
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Specialised Human Cell Line Recombinant Factor VIII
More information
Spend profile
| Financial year | Budget |
|---|---|
| 2017/2018 | £2,070,000 |
| 2018/2019 | £2,070,000 |
About the buyer
Contact name
Alison Greenwood
Address
Commercial Medicines Unit
2nd Floor, Rutland House
Runcorn
WA7 2ES
England
Share this notice
All content is available under the
